Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL2200048	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Import Drug Application	2022-04-19		FibroGen Inc			view
JXSL2100030	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Import Drug Application	2021-02-23	珐博进（中国）医药技术开发有限公司	FibroGen (China) Medical Technology Development Co Ltd;FibroGen Inc	In Review	2021-02-22	view
JXSL2100020	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Import Drug Application	2021-02-10	珐博进（中国）医药技术开发有限公司	FibroGen (China) Medical Technology Development Co Ltd;FibroGen Inc	In Review	2021-02-10	view
JXSL2000069	Pamrevlumab	pamrevlumab	Injection	Biological Products	Import Drug Application	2020-06-04	珐博进（中国）医药技术开发有限公司	FibroGen (China) Medical Technology Development Co Ltd;FibroGen Inc	In Review	2020-06-03	view
JXSL2000068	Pamrevlumab	pamrevlumab	Injection	Biological Products	Import Drug Application	2020-06-09	珐博进（中国）医药技术开发有限公司	FibroGen (China) Medical Technology Development Co Ltd;FibroGen Inc	In Review	2020-06-03	view
JXSB2200116	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Supplementary Application	2022-09-10		Boehringer Ingelheim Pharma Gmbh & Co KG;FibroGen Inc			view
JXSB2200037	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Supplementary Application	2022-03-25		Boehringer Ingelheim Pharma Gmbh & Co KG;FibroGen Inc			view
JXSB2200006	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Supplementary Application	2022-01-11		Boehringer Ingelheim Pharma Gmbh & Co KG;FibroGen Inc			view
JXSB2200003	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Supplementary Application	2022-01-06		Boehringer Ingelheim Pharma Gmbh & Co KG;FibroGen Inc			view
JXSB2000031	Pamrevlumab	pamrevlumab	Injection	Biological Products(1)	Supplementary Application	2020-10-15	珐博进（中国）医药技术开发有限公司	FibroGen (China) Medical Technology Development Co Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG;FibroGen Inc	In Review	2020-10-14	view